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ABSTRACT
Objectives To study the analgesic effect of acupuncture
andplaceboacupunctureandtoexplorewhetherthetype
of the placebo acupuncture is associated with the
estimated effect of acupuncture.
Design Systematic review and meta-analysis of three
armed randomised clinical trials.
Data sources Cochrane Library, Medline, Embase,
Biological Abstracts, and PsycLIT.
Data extraction and analysis Standardised mean
differencesfromeachtrialwereusedtoestimatetheeffect
of acupuncture and placebo acupuncture. The different
types of placebo acupuncture were ranked from 1 to 5
according to assessment of the possibility of a
physiologicaleffect,andthisrankingwasmeta-regressed
with the effect of acupuncture.
Data synthesis Thirteen trials (3025 patients) involving a
variety of pain conditions were eligible. The allocation of
patients was adequately concealed in eight trials. The
clinicians managing the acupuncture and placebo
acupuncturetreatmentswerenotblindedinanyofthetrials.
Oneclearlyoutlyingtrial(70patients)wasexcluded.Asmall
difference was found between acupuncture and placebo
acupuncture: standardised mean difference −0.17 (95%
confidenceinterval −0.26to −0.08),correspondingto4mm
(2 mm to 6 mm) on a 100 mm visual analogue scale. No
statistically significant heterogeneity was present (P=0.10,
I
2=36%).Amoderatedifferencewasfoundbetweenplacebo
acupuncture and no acupuncture: standardised mean
difference −0.42 (−0.60 to −0.23). However, considerable
heterogeneity (P<0.001, I
2=66%) was also found, as large
trials reported both small and large effects of placebo. No
association was detected between the type of placebo
acupuncture and the effect of acupuncture (P=0.60).
Conclusions A small analgesic effect of acupuncture was
found, which seems to lack clinical relevance and cannot
be clearly distinguished from bias. Whether needling at
acupuncture points, or at any site, reduces pain
independently of the psychological impact of the
treatment ritual is unclear.
INTRODUCTION
Acupuncture is commonly used for the treatment of
pain. In traditional Chinese medicine the concepts of
“meridian” and the vital energy “Qi” form part of the
theoretical basis for needling at specific acupuncture
points.
12Studies indicate that penetration of a needle
through the skin, whether at an acupuncture point or
not, has physiological effects.
3-5 The “gate control
theory” and the release of endogenous opioids have
been suggested as explanations for the apparent
analgesic effect of acupuncture.
6-8
In 2005 two large, high quality trials in patients with
headache found little difference between the effects of
acupunctureandplaceboacupuncturebutasubstantial
difference between placebo acupuncture and no
acupuncture.
w1 w2 This result differed from that of a
large systematic review comparing all placebo inter-
ventions with no treatment that found only a small to
moderate analgesic effect of placebo, which could not
be clearly distinguished from reporting bias owing to
the inevitable lack of blinding of the no treatment
groups.
910We therefore wanted to analyse all trials of
acupuncture for pain that had two control groups
consistingofplaceboacupunctureandnoacupuncture.
Our objectives were to study the analgesic effect of
acupuncture and placebo acupuncture and to explore
whether the type of placebo acupuncture is associated
with the estimated effect of acupuncture.
METHODS
We systematically reviewed clinical trials of acupunc-
ture treatment for pain that randomised patients to
acupuncture,placeboacupuncture,ornoacupuncture.
Search strategy
The literature searches were very comprehensive and
have been described in the Cochrane review of the
effect of placebo interventions.
11 We searched the
Cochrane Library, Medline, Embase, Biological
Abstracts, and PsycLIT. The last search included all
trials published before 1 January 2008.
Inclusion criteria
We included all trials that labelled the intervention
“acupuncture”—for example, traditional acupuncture
and electro-acupuncture. We excluded trials that used
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ual acupressure.
Nocleardefinitionofplaceboacupunctureexists,so
we accepted the placebo interventions used by the
authors of the trial reports, such as insertion of needles
into non-acupuncture points or use of non-penetrating
needles. We excluded trials in which the no acupunc-
turegroupreceivedanintendedbasiccarethatdiffered
from that provided to the acupuncture and placebo
acupuncture groups—for example, if an educational
programme was part of the intended basic care in the
no acupuncture group but not in the other groups.
We included trials if the pain had been estimated by
the patients (self reported pain) on a visual analogue
scale or another ranking scale. When several pain
scaleshadbeenused,theywerepresentedtotwoofthe
authors (AH and PCG) who, blinded for the results,
chose the most relevant one, preferably a visual
analogue scale as this is the most commonly used
scale in pain studies. When pain had been assessed at
several time points we chose the first time point after
the end of treatment. All authors evaluated the
eligibility of the trials, resolving disagreements by
discussion.
Data extraction
One author (MVM) extracted data, and the other
authors checked them. We noted the type of clinical
problem that caused the pain, type of pain scales,
number of patients, duration of treatment, number of
sessions,andnatureofanyconcomitanttreatment.We
describedin detail the type of acupuncture and type of
placebo intervention in each trial. We noted the
average pain after the end of treatment, and the
standard deviation, or used changes from baseline if
such data were not available.
Assessment of risk of bias
One author (AH) assessed risk of bias in the trials, and
another author (PCG) checked it. We noted whether
the allocation of patients in each trial was adequately
concealed, whether patients had been described as
blinded (or masked), and whether dropout was below
15%.Weconsideredsuchtrialstohavelowriskofbias.
We assessed small sample size bias with funnel plots.
12
Data analysis
For each trial, we calculated the standardised mean
difference, which is the difference between the means
divided by the pooled standard deviation. In three
cases in which standard deviations were not available
and could not be derived for a particular trial,
w3-w5 we
estimated the standard deviation on the basis of the
values in the other trials. We calculated the standard
deviation/mean for these trials, selected the median
value, and multiplied it with the mean from the trial
with a missing standard deviation.
In two cases in which more than one acupuncture
group was used,
w3 w6 such as high frequency and low
frequency acupuncture treatment, we combined the
results from both groups into a weighted mean and a
pooled variance.
13 After our initial data extraction we
became aware that for one trial we had chosen a scale
thatprimarilymeasuredqualityofpain(Schmerzemp-
findungsskala) and not intensity of pain.
w7 Therefore,
we used data from the only other eligible scale, the
Western Ontario and McMaster Universities pain
subscale.
We pooled the standardised mean differences from
the trials by using meta-analysis, comparing the effect
of acupuncture with that of placebo acupuncture and
the effect of placebo acupuncture with that of no
acupuncture.
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Fig 1 | Meta-analysis of acupuncture versus placebo acupuncture
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authors’ primary outcome.
14 In unplanned sensitivity
analyses, we also studied the impact of the methodo-
logical quality of the trials and of the type of
acupuncture. We assumed that trials with clearly
concealed allocation, explicit blinding of patients,
and a dropout rate below 15% had lower risk of bias
than other trials.
91013We also assumed that trials in
whichexperiencedacupuncturistswere allowedtouse
individually chosen acupuncture points (in addition to
several fixed points) could differ in effect from other
trials.
We furthermore studied whether the difference
between acupuncture and placebo acupuncture was
related to the type of placebo, by using meta-
regression. For this purpose, one author (PCG),
blinded to the results, evaluated the placebo inter-
ventions on a ranking scale from 1 to 5, where 1
represented a placebotreatmentthat mostlikely could
produce physiological effects and 5 represented the
opposite. For this evaluation, we considered point of
insertion,needlesize,depthofinsertion,penetrationof
the skin, achievement of Qi, and manual stimulation.
Another author (AH) checked this evaluation. Finally,
wedidasupplementarysubgroupanalysisinwhichwe
compared the effect of acupuncture on the basis of
whetherornottheplaceboacupuncturepenetratedthe
skin.
We used Review Manager 5 and Stata 8.2 for final
analyses. We used a random effects model if hetero-
geneity existed (P<0.10) and a fixed effect model
otherwise.
RESULTS
The search included 234 trials eligible for our updated
Cochrane review (in progress) of all types of placebo
interventions.
910 From this sample we identified 20
potentially eligible trials for this review. We excluded
seven trials—six because they studied transcutaneous
electrical nerve stimulation and one because the
intervention was manual acupressure. We included
13 trials of acupuncture for pain (3025 patients)
(table 1).
w1-w13
The clinical conditions were knee osteoarthritis,
w7-w9
tension type headache,
w1 migraine,
w2 low back pain,
w10-
w12fibromyalgia,
w4abdominalscarpain,
w13postoperative
pain,
w3 w6 and procedural pain during colonoscopy.
w5
The duration of treatment varied from one day to
12 weeks (table 1).
Eight trials had clearly concealed the allocation of
patients.
w1 w2 w7-w11 w13Notrialsreportedblindingofthe
clinicians managing the acupuncture and placebo
acupuncture treatments, whereas blinding of the
patients was explicitly reported in 10 trials.
w1-w3 w6-w12
In five trials the acupuncture treatment involved
multiple sessions with experienced acupuncturists
who could choose additional acupuncture points at
their discretion.
w1 w2 w4 w7 w11
Table 2describes theplacebotreatments.Intwotrials
the placebo procedures consisted of non-penetrative
needling.
w4 w9 In 11 trials the placebo procedure
penetratedtheskin:seventrialsusedsuperficialneedling
atnon-acupuncturepointswithfineneedles,avoidingQi
andmanualstimulation,andfourtrialsusedotherforms
of penetrative needling.
w3 w5 w6 w13
Table 1 |Characteristics of trials
Trial Clinical problem
Trial size—No randomised
(No; % dropouts) Blinding Concealment of allocation Pain scale
Treatment duration
(No of sessions)*
Melchart
w1 Tension headache 270 (30; 11%) Patients Centralised telephone
randomisation
Rating scale (1-10) 8 weeks (12); evaluation at
12 weeks
Linde
w2 Migraine 302 (20; 7%) Patients Centralised telephone
randomisation
Rating scale (0-10) 8 weeks (12); evaluation at
12 weeks
Scharf
w8 Osteoarthritis 1039 (57; 5%) Patients Central randomisation WOMAC (0-10) 6 weeks (10); evaluation at
13 weeks
Witt
w7 Osteoarthritis 300 (14; 5%;) Patients Centralised telephone
randomisation
WOMAC (0-10) 8 weeks (12)
Foster
w9 Osteoarthritis 352 (19; 5%) Patients Central telephone randomisation WOMAC (0-10) 3 weeks† (6); evaluation at
6w e e k s
Brinkhaus
w11 Low back pain 301 (17; 6%) Patients Centralised telephone
randomisation
VAS (0-100 mm) 8 weeks (12)
Molsberger
w10 Low back pain 186 (12; 6%) Patients Central telephone randomisation VAS (0-100 mm) 4 weeks (12)
Leibing
w12 Low back pain 150 (36; 24%) Patients Unclear VAS change (0-10 cm) 12 weeks (20)
Wang
w6 Postoperative pain 101 (unclear) Patients Unclear VAS (0-100 mm) 1 day (1)
Lin
w3 Postoperative pain 100 (unclear) Patients Unclear VAS (0-100 mm) 1 day (1)
Fanti
w5 Colonoscopy 30 (unclear) Unclear Unclear Rating scale (1-5) 1 day (1)
Sprott
w4 Fibromyalgia 30 (unclear) Unclear Unclear VAS (0-10) 3 weeks (6)
Kotani
w13 Scar pain 70 (unclear) Unclear Sequentially sealed opaque
envelopes
VAS (0-10 cm) 4 weeks (20)
VAS=visual analogue scale; WOMAC=Western Ontario and McMaster Universities pain subscale.
*Timing of evaluation is identical to treatment duration if not otherwise specified.
†Acupuncture and placebo acupuncture groups received three weeks of needling during six week standard care programme.
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care. This concomitant treatment, also given to the no
acupuncture group, typically consisted of analgesics
(n=13) and physiotherapy (n=5). In general, the
patients in the no acupuncture groups used more
concomitant treatment than did the patients in the
placeboacupunctureandacupuncturegroups,withno
clear difference between the last mentioned groups
(table 2).
Acupuncture versus placebo acupuncture
Substantial heterogeneity was present in the compar-
ison between acupuncture and placebo acupuncture
(P<0.001, I
2=66%). A trial by Kotani et al was a clear
outlier—standardised mean difference −1.66 (95%
confidence interval −2.34 to −0.98).
w13 This trial,
doneinJapan,included70patients(2%ofoursample),
involved an unusual procedure of needling in painful
scars, and whether the patients in the placebo
acupunctureandtheacupuncturegroupswereblinded
was unclear; one third of the patients in the untreated
group complained of pain caused by repeated injec-
tions of local anaesthetics. We excluded this trial from
all further analyses, after which the heterogeneity was
substantially reduced (P=0.10, I
2=36%).
We found a statistically significant difference
between acupuncture and placebo acupuncture
(P<0.001)—pooled standardised mean difference
Table 2 |Type of interventions
Trial
No acupuncture (standard
care only) Acupuncture + standard care Placebo acupuncture + standard care
Potential differences in concomitant
therapies
Melchart
w1 Treatment of acute
headaches as needed
following current guidelines
Needling at “basic” points bilaterally;
additional points chosen individually;
achievement of “Qi” and manual stimulation
at least once per session
Superficial needling at non-acupuncture
points using fine needles; avoided Qi and
manual stimulation
No acupuncture group had more days with
analgesic drugs than acupuncture group
(P<0.001);nodifferencebetweenothergroups
(P=0.12)
Scharf
w8 10clinicalvisits;oralNSAID;
up to six physiotherapy
sessions
Local acupuncture points, according to
theory of Bi syndrome, as obligatory points;
additionally, 2 of 16 defined acupuncture
points could be chosen
Superficial needling at non-acupuncture
points; depth up to 0.5 cm without Qi; no
stimulation; same type of needles used
No acupuncture group had more visits to
physiotherapy and more use of analgesics
than acupuncture and placebo acupuncture
groups; no statistical significance of data
reported
Linde
w2 Treatment of acute
headaches as needed
following current guidelines
Bilateral needle insertion in basic points;
additional points chosen individually
according to patients’ symptoms;
achievementofQiandmanualstimulationat
least once per session
Superficial needling at non-acupuncture
points; fine needles used; Qi and manual
stimulation avoided
No acupuncture group had more use of
analgesics than acupuncture group (P<0.01);
no difference between acupuncture and
placebo acupuncture groups (P=0.65)
Brinkhaus
w11 NSAID if required Local and distant points bilaterally;
additional points chosen individually;
achievementofQiandmanualstimulationat
least once per session
Superficial needling (needles 20-40 mm) on
non-acupuncture points; fine needles used;
Qi and manual stimulation avoided
Both placebo acupuncture (P=0.009) and no
acupuncture groups (P<0.001) had more time
on analgesics than acupuncture group
Witt
w7 NSAID if required Local and distant points; additional points
could be chosen; achievement of Qi and
manualstimulationatleastoncepersession
Superficial needling at non-acupuncture
points; fine needles used; manual
stimulation and Qi avoided
No statistically significant difference in days
with drugs between the three groups
Foster
w9 Advice and exercise by
physiotherapist; fixed dose
NSAID
6-10 points from 16 local and distal points;
manipulations to achieve Qi
Non-penetrative needling; no attempt to
achieve Qi
Nodifferenceinuseofanalgesicdrugsorvisits
to general practitioner
Molsberger
w10 Oral NSAID, back school,
physiotherapy, physical
exercise, mud packs, and
infrared therapy
Standard points in the lumbar region and
distal points; mild to strong manipulation
depending on pain; achievement of Qi
Superficial (depth <1 cm) needling at non-
acupuncture points; apparently Qi and
manipulation avoided
No acupuncture group had least use of
analgesics; no statistical significance
reported
Leibing
w12 Continuation of existing
drugs; no new drugs; 26
sessions of physiotherapy
Body acupuncture and ear acupuncture, 10-
30 mm; achievement of Qi and manual
stimulation.
Superficial needling at non-acupuncture
points; needles not stimulated (no Qi)
Differences in use of concomitant treatment
not reported
Sprott
w4 Paracetamol, exercise,
heating, cooling, and
electrotherapy
Acupuncture points needled according to
patient’s symptoms
Turned off “Laser Sonde” held over symptom
points; no mechanical pressure
Differences in use of concomitant treatment
not reported
Fanti
w5 Intravenous midazolam
boluses on demand, and
one dose before
colonoscopy
Bilateral needling at acupuncture points
considered relevant for both sedation and
abdominal distension; electrical stimulation
Needling at non-acupuncture points with
electrical stimulation
No acupuncture group had more additional
midazolam boluses than acupuncture group
and placebo acupuncture group (P=0.01)
Lin
w3 One dose of intramuscular
pethidine; intravenous
morphine on demand
Bilateral needling at points Zusanli; after
achievement of Qi electrical stimulation
Needling at acupuncture points but without
current; indicator light on
No acupuncture group had more morphine
delivered than other groups (P<0.05)
Kotani
w13 Infiltration of local
anaesthetics; oral NSAID
before and after treatment
Needling at painful points; needles kept in
place for 24 hours
Needling at non-painful points No acupuncture group had greater
consumption of analgesics than acupuncture
group (P<0.001); 30% of no acupuncture
patients found
infiltration of local anaesthetics painful
Wang
w6 Intravenous hydromorphine
on demand; preoperative
midazolam
Cutaneous electrodes placed at Hegu point,
on hand, and on either side of incision;
electrical alternating stimulation
Needling at acupuncture points but no
electrical stimulation; indicator lights on
No acupuncture group had more
hydromorphine delivered than acupuncture
group (P<0.05)
NSAID=non-steroidal anti-inflammatory drug.
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funnelplotwassymmetricalwithaclearpeak(datanot
shown).
Placebo acupuncture versus no acupuncture
Substantial heterogeneity existed in the comparison
between placebo acupuncture and no acupuncture
(P<0.001, I
2=66%) (fig 2). We found a statistically
significant difference between placebo acupuncture
and no acupuncture (P<0.001)—pooled standardised
mean difference −0.42 (−0.60 to −0.23). On visual
inspection, the funnel plot had a broad peak, as large
trials reported both small and large effects of placebo;
furthermore, small trials tended to report small effects
(data not shown).
Secondary analyses
In two trials,
w3 w4 we could not define the authors’
primary outcome, so the sensitivity analysis included
10trials.Intwotrials,
w5 w12ourchosenoutcomewasthe
same as that of the authors (table 1). Substantial
heterogeneity existed in the comparison between
acupuncture and placebo acupuncture (P<0.001,
I
2=73%). The pooled standardised mean difference
was −0.26 (−0.46 to −0.07) (P< 0.001). For the
comparison of placebo acupuncture with no acupunc-
ture, substantial heterogeneity was also present
(P<0.001, I
2=59%). The pooled standardised mean
difference was −0.48 (−0.65 to −0.30) (P=0.009).
When we restricted the analysis to the seven trials
with clearly concealed allocation, explicit blinding of
patients, and dropout rate less than 15%, substantial
heterogeneity existed in the comparison between
acupuncture and placebo acupuncture (P=0.01,
I
2=63%). The pooled standardised mean difference
was−0.19(−0.35to−0.02)(P=0.03).Heterogeneitywas
alsopresentinthesimilarcomparisonbetweenplacebo
acupuncture and no acupuncture (P=0.001, I
2=72%).
The pooled standardised mean difference was −0.54
(−0.75 to −0.33) (P<0.001).
When we restricted the analysis to the five trials that
involved multiple sessions of acupuncture treatment
with experienced acupuncturists who could choose
additional acupuncture points at their discretion, we
also found heterogeneity in the comparison between
acupuncture and placebo acupuncture (P=0.07,
I
2=53%). The pooled standardised mean difference
was −0.23 (−0.45 to −0.01) (P=0.04). Heterogeneity
alsoexistedinthesimilarcomparisonbetweenplacebo
acupuncture and no acupuncture (P=0.09, I
2=49%).
The pooled standardised mean difference was −0.71
(−0.96 to −0.45) (P<0.001).
Type of placebo acupuncture
We ranked the various placebo acupuncture inter-
ventions on a 1-5 scale, where 1 represents a placebo
treatmentthatwasmostlikelytoproducephysiological
effects. We ranked needling at acupuncture points
without electrical stimulation but indicator lights on as
1
w3 w6; needling at non-acupuncture points with elec-
trical stimulation as 2
w5; superficial needling at non-
acupuncture points (20-50 mm) avoiding Qi and
manual stimulation as 3
w1 w2 w7 w8 w10-w12; non-penetrat-
ing needle as 4
w9; and laser turned off, held over the
symptomatic points without using any mechanical
pressure as 5.
w4
A meta-regression of the 12 trials found no
statistically significant relation between the type of
placebo intervention and the effect of acupuncture
(P=0.60). Supplementary subgroup analyses found a
statistically significant difference in effect of acupunc-
ture between the two trials using non-penetrative
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Fig 2 | Meta-analysis of placebo acupuncture versus no acupuncture
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0.07, −0.18 to 0.32) and the 10 trials using penetrative
placebo needles(pooled standardisedmean difference
−0.21,−0.30to−0.11)(P=0.04).Thus,contrarytowhat
would be expected, the tendency was for larger effects
of acupuncture when the comparative placebo proce-
dure was penetrative.
DISCUSSION
Wefoundasmalldifferencebetweenacupunctureand
placebo acupuncture and a moderate difference
between placebo acupuncture and no acupuncture.
Theeffectofplaceboacupuncturevariedconsiderably.
Strengths and weaknesses
Ourreviewisthefirstthatidentifiesandanalysesthree
armedtrialsofacupunctureforpain,thusprovidingan
estimate of the general analgesic effect of acupuncture
and its direct comparison with the analgesic effect of
placebo acupuncture. The review is fairly large,
includes several trials of high methodological quality,
and covers a broad range of common painful condi-
tions. Furthermore, our main results were similar to
those found in the subgroups of trials with low risk of
bias, in trials using multiple sessions of experienced
acupuncturists choosing acupuncture points at their
discretion, and when we analysed the primary out-
comes of the trials (instead of the outcome we had
chosen).
Allincludedtrialsprovidedvarioustypesofstandard
care to the patients, and we excluded trials with
differentintendedstandardcareforthenoacupuncture
group compared with the acupuncture and placebo
acupuncturegroups.
15-17 Thus,ourfindingsarelimited
to the additive effect of acupuncture and placebo
acupuncture. The standard care was unlikely to have
resultedina“ceilingeffect”preventingthedetectionof
anybeneficialeffectofacupuncture,becausewefound
an effect of placebo acupuncture beyond that of
standard care.
Our meta-regression analysis found no association
betweentypeofplaceboandeffectofacupuncture.We
did find a greater effect of acupuncture in the 10 trials
with penetrative placebo needles compared with the
only two trials that used non-penetrative placebo
needles (P=0.04). This is contrary to what one would
haveexpected,andweregarditasachancefinding.We
notethatourmeta-regressionwasbasedonasubjective
ranking of the possibility of a physiological effect of
placebo, and that both the subgroup analysis and the
meta-regressionareobservationalinnature.However,
our findings are similar to that of a randomised trial
reporting no difference in analgesic effect between
three types of placebo acupuncture: acupuncture
considered specific for another disease, needle inser-
tion at non-acupuncture points, and non-penetrative
simulated acupuncture.
18
We found a tendency for an increase in the use of
analgesic drugs in the no acupuncture groups com-
paredwiththeplaceboandacupuncturegroups,which
would tend to underestimate the effect of placebo
acupuncture.Wefoundnotendencyforanydifference
in use of concomitant treatment between the placebo
groups and the acupuncture groups.
Our sensitivity analyses of the authors’ primary
outcomes found slightly larger effects of acupuncture
and placebo, as well as more heterogeneous results.
However, the trials had very dissimilar primary
outcomes (such as days with headache and number of
analgesicdoses)andprimaryoutcomesinclinicaltrials
are often changed retrospectively.
14 We excluded one
trial as a clear outlier, but the proportion of excluded
patients was small and had little effect on our effect
estimates.
Other studies
Our finding of limited, at best, analgesic effects of
acupuncture corresponds with the seven Cochrane
reviews on acupuncture for various types of pain,
whichallconcludedthatnoclearevidenceexistedofan
analgesic effect of acupuncture.
19-25 Most stressed the
methodological shortcomings of the included trials.
Our finding of a moderate difference between
placebo acupuncture and no acupuncture (standar-
disedmeandifference−0.42)agreesfairlywellwithour
previous review of the effect of placebo in general.
910
Although we previously found an overall difference in
standardisedmeandifferenceof−0.25forpain,wealso
saw a tendency for larger effects when the placebo
intervention was procedural—for example, a sham
acupuncture needle (standardised mean difference
−0.33)—and not merely a placebo tablet (standardised
mean difference −0.20).
Meaning of our review
Interpreting a standardised mean difference clinically
maybechallenging.Onthebasisofthemeanstandard
deviation from the trials that had used visual analogue
scales, the effect of acupuncture (standardised mean
difference −0.17, −0.26 to −0.07) corresponds to a
reductionof4(2to6)mmona100mmscale.Theeffect
of placebo acupuncture (standardisedmean difference
−0.42(−0.60to−0.23),correspondstoareductionof10
(6 to 15) mm.
Attempts at defining a clinically minimal pain
improvementhavereachedquitedifferentconclusions
and have often reported percentage improvement and
not an absolute effect size as we have.
2627 However, a
consensusreportcharacteriseda10mmreductionona
100 mm visual analogue scale as representing a
“minimal” change or “little change.”
27 Thus, the
apparent analgesic effect of acupuncture seems to be
below a clinically relevant pain improvement.
Our pooled effect of placebo acupuncture (standar-
dised mean difference −0.42) is based on trials with
effectsthatvarymuchmorethanisexpectedbychance.
Some of the large trials report an effect of placebo
acupuncture that is of clear clinical relevance—for
example,standardisedmeandifference−0.95,
w2corre-
spondingto24mmona100mmvisualanaloguescale
—whereas others find effects that seem to be of limited
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difference −0.21,
w9 corresponding to 5 mm.
Considerable heterogeneity existed (I
2=66%) when
we compared placebo acupuncture with no acupunc-
ture but not when we compared acupuncture with
placeboacupuncture(I
2=36%),althoughbothanalyses
were based on the same trials and the same outcomes
and approximately one third of the patients were
identical (those in the placebo groups). Thus, more
variation seems to occur in the no acupuncture groups
than in the acupuncture groups.
Lack of blinding is inherent in the no acupuncture
groups.
28 Variations in reporting bias, in use of
concomitanttreatment,and in the interaction between
thepatientandthecareprovidercouldexplainsomeof
the observed variation in the effect of placebo.
Insufficient blinding is also a problem for the
comparison between acupuncture and placebo acu-
puncture. In all trials, the acupuncturist knew what
constituted true acupuncture and sham acupuncture.
Furthermore, in some trials, a noticeable difference
existed between the acupuncture and the placebo
acupuncture, in most cases because the placebo
acupuncture did not involve manual stimulation and
attempts to induce Qi. Close interaction between
patient and therapist is typical for acupuncture and
will often involve suggestive components. For exam-
ple,whenpatientsareaskedwhethertheyfeelQiahigh
proportion of patients will say yes, even when they
have been treated with a non-penetrating placebo
acupuncture needle.
29 The incomplete blinding of the
patients, and the interaction between the fully
unblinded acupuncturist and the patients, could
explain part of—or perhaps all of—the observed
small effect.
Unanswered questions and future research
Our findings question both the traditional foundation
of acupuncture, which is based on the existence of
meridians and Qi sensations, and the prevailing
hypothesis that acupuncture has an important effect
on pain in general. If this hypothesis is wrong, and our
results point to that, then acupuncture would seem to
be unlikely to have an effect on pain related only to
certain conditions, but further studies may examine
this question.
Insomesituationsplaceboacupunctureisassociated
with large analgesic effects, but in other situations
similar procedures cause no, or only small, effects.
Thus, to regard placebo acupuncture as a universally
effective “super placebo” would be inappropriate.
Important heterogeneity remains unexplained and
calls for further studies on the underlying mechanisms
of the effects of placebo acupuncture and placebo in
general.
Wesuggestthatfuturetrialsonacupunctureforpain
focusontwostrategies.Firstly,researcherscouldtryto
reduce bias by ensuring blinding when possible. For
example, blinding of the healthcare provider can be
achieved by having the needling done by acupuncture
naïve clinicians blinded to the hypothesis of the trial.
Secondly, researchers could try to separate the effects
involved: the physiological effect of needling at
acupuncturesitesoratothersitesandthepsychological
effect of the treatment ritual or of the patient-provider
interaction more broadly.
30
Conclusion
We found a small analgesic effect of acupuncture that
seems to lack clinical relevance and cannot be clearly
distinguishedfrombias.Whetherneedlingatacupunc-
ture points, or at any site, reduces pain independently
of the psychological impact of the treatment ritual is
unclear.
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